Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs
Ep. Van Puijenbroek et al., Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs, EUR J CL PH, 56(9-10), 2000, pp. 733-738
Objective: Drug-drug interactions are relatively rarely reported to spontan
eous reporting systems (SRSs) for adverse drug reactions. For this reason,
the traditional approach for analysing SRS has major limitations for the de
tection of drug-drug interactions. We developed a method that may enable si
gnalling of these possible interactions, which are often not explicitly rep
orted, utilising reports of adverse drug reactions in data sets of SRS. As
an example, the influence of concomitant use of diuretics and non-steroidal
anti-inflammatory drugs (NSAIDs) on symptoms indicating a decreased effica
cy of diuretics was examined using reports received by the Netherlands Phar
macovigilance Foundation Lareb.
Methods: Reports received between 1 January 1990 and 1 January 1999 of pati
ents older than 50 years were included in the study. Cases were defined as
reports with symptoms indicating a decreased efficacy of diuretics, non-cas
es as all other reports. Exposure categories were the use of NSAIDs or diur
etics versus the use of neither of these drugs. The influence of the combin
ed use of both drugs was examined using logistic regression analysis. Resul
ts: The odds ratio of the statistical interaction term of the combined use
of both drugs was increased [adjusted odds ratio 2.0, 95% confidence interv
al (CI) 1.1-3.7], which may indicate an enhanced effect of concomitant drug
use.
Conclusion: The findings illustrate that spontaneous reporting systems have
a potential for signal detection and the analysis of possible drug-drug in
teractions. The method described may enable a more active approach in the d
etection of drug-drug interactions after marketing.